Researchers hopeful vaccines for cancer, heart disease will be ready by 2030
Studies into vaccinations for cancer and cardiovascular and autoimmune diseases are showing "tremendous promise," with the success of COVID-19 mRNA vaccines accelerating this technology.
As The Guardian explains, "therapies based on mRNA work by teaching cells how to make a protein that triggers the body's immune response against disease." An mRNA-based cancer vaccine, for example, would "alert the immune system to a cancer that is already growing in a patient's body, so it can attack and destroy it, without destroying healthy cells."
Dr. Paul Burton, chief medical officer of Moderna, told The Guardian he thinks his pharmaceutical company will offer treatments for "all sorts of disease areas" by 2030, and is developing cancer vaccines targeting multiple types of tumors. By offering personalized cancer vaccines, it will "save many hundreds of thousands, if not millions, of lives," Burton said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
In late 2022, Moderna announced a phase two clinical trial found the company's personalized mRNA cancer vaccine combined with Merck's immunotherapy drug Keytruda reduced the recurrence of melanoma, the most serious type of skin cancer, by 44 percent. In February, the Food and Drug Administration gave this combination a Breakthrough Therapy Designation, which expedites the development and review of drugs meant to treat life-threatening conditions.
Vaccine studies now underway are showing "tremendous promise," Burton said, and he estimates that 10 years from now, "we will be approaching a world where you truly can identify the genetic cause of a disease and, with relative simplicity, go and edit that out and repair it using mRNA-based technology."
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia is night editor for TheWeek.com. Her writing and reporting has appeared in Entertainment Weekly and EW.com, The New York Times, The Book of Jezebel, and other publications. A Southern California native, Catherine is a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Blind people will listen to next week's total eclipse
Speed Read While they can't see the event, they can hear it with a device that translates the sky's brightness into music
By Peter Weber, The Week US Published
-
Melting polar ice is messing with global timekeeping
Speed Read Ice loss caused by climate change is slowing the Earth's rotation
By Peter Weber, The Week US Published
-
Why the Y chromosome is vanishing and what this means for the future
The Explainer A new sex gene could be on the evolution pipeline
By Devika Rao, The Week US Published
-
An amphibian that produces milk?
speed read Caecilians, worm-like amphibians that live underground, produce a milk-like substance for their hatchlings
By Peter Weber, The Week US Published
-
Jupiter's Europa has less oxygen than hoped
speed read Scientists say this makes it less likely that Jupiter's moon harbors life
By Peter Weber, The Week US Published
-
Why February 29 is a leap day
Speed Read It all started with Julius Caesar
By Peter Weber, The Week US Published
-
US spacecraft nearing first private lunar landing
Speed Read If touchdown is successful, it will be the first U.S. mission to the moon since 1972
By Peter Weber, The Week US Published
-
Scientists create 'meaty' rice for eco-friendly protein
Speed Read Korean scientists have invented a new hybrid food, consisting of beef muscle and fat cells grown inside grains of rice
By Peter Weber, The Week US Published